CLINICAL_TRIALS
trial_result
· 2017-11-06
Clinical Trial Update: Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer [Phase 1, Phase 2]
Summary
A safety and tolerability study of WST11 in patients with localized prostate cancer has completed Phase 1/2 testing with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Steba Biotech S.A. | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-11-06